Cell Source ( ($CLCS) ) has released a notification of late filing. Cell Source, Inc. has announced a delay in filing its Form 10-K (Yearly ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

The Global Single-cell Analysis Market is projected to grow at a CAGR of 9.5% from 2026 to 2033, according to a new report published by Verified Market Reports ®. The report reveals that the market ...

The HZI team has developed an AI-powered computer model that, for the first time, reveals the aging process at the cellular ...

CHO cells were the protein production platform used in 89% of the biologics drugs approved between 2018 and 2022, and their ...

For human health, prematurely aging cells are a big problem. When a cell ages and stops growing, its function changes, which can cause or worsen cardiovascular disease, Alzheimer's disease and other ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. Medical history made at Cohen Children's Medical ...

770-2030 from the U.S. and Canada and entering conference ID number 6707203. About Lineage Cell Therapeutics, Inc. Lineage Cell Therapeutics is a clinical-stage biotechnology company developing ...

This is the first study to identify and develop small molecules -- termed "molecular glues" -- that enhance the interaction between ChREBPα and 14-3-3 proteins in pancreatic beta cells.

The next frontier of stem cell transplantation might involve the eyes. In research out today, scientists report that an experimental therapy has helped people with otherwise untreatable injuries ...